An Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustmentopen accessAn Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustment
- Other Titles
- An Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustment
- Authors
- Park, SW[Park, Sung Woon]; Lee, S[Lee, Seunghyun]; Cha, WC[Cha, Won Chul]; Hur, KY[Hur, Kyu Yeon]; Kim, JH[Kim, Jae Hyeon]; Lee, MK[Lee, Moon-Kyu]; Park, SM[Park, Sung-Min]; Jin, SM[Jin, Sang-Man]
- Issue Date
- Feb-2020
- Publisher
- KOREAN DIABETES ASSOC
- Keywords
- Computer simulation; Electronic health records; Insulin; Medical records systems; computerized
- Citation
- DIABETES & METABOLISM JOURNAL, v.44, no.1, pp.56 - 66
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- DIABETES & METABOLISM JOURNAL
- Volume
- 44
- Number
- 1
- Start Page
- 56
- End Page
- 66
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/5772
- DOI
- 10.4093/dmj.2018.0227
- ISSN
- 2233-6079
- Abstract
- Background: We aimed to describe the outcome of a computerized intravenous insulin infusion (CII) protocol integrated to the electronic health record (EHR) system and to improve the CII protocol in silico using the EHR-based predictors of the outcome. Methods: Clinical outcomes of the patients who underwent the CII protocol between July 2016 and February 2017 and their matched controls were evaluated. In the CII protocol group (n =91), multivariable binary logistic regression analysis models were used to determine the independent associates with a delayed response (taking >= 6.0 hours for entering a glucose range of 70 to 180 mg/dL). The CII protocol was adjusted in silico according to the EHR-based parameters obtained in the first 3 hours of CII. Results: Use of the CII protocol was associated with fewer subjects with hypoglycemia alert values (P=0.003), earlier (P=0.002), and more stable (P=0.017) achievement of a glucose range of 70 to 180 mg/dL. Initial glucose level (P=0.001), change in glucose during the first 2 hours (P=0.026), and change in insulin infusion rate during the first 3 hours (P= 0.029) were independently associated with delayed responses. Increasing the insulin infusion rate temporarily according to these parameters in silico significantly reduced delayed responses (P < 0.0001) without hypoglycemia, especially in refractory patients. Conclusion: Our CII protocol enabled faster and more stable glycemic control than conventional care with minimized risk of hypoglycemia. An EHR-based adjustment was simulated to reduce delayed responses without increased incidence of hypoglycemia.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.